Research location
Sumy
Ukraine
Advertisement
Research activity in Sumy
UkraineCureCurrent currently publishes aggregate city-level research activity for this location: 116 trials and 120 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sumy
116 linked trials · page 1 of 3Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisNCT05201638 · 2022-01-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of INCB086550 in Select Solid TumorsNCT04629339 · 2021-09-02 · 1 site observation
TERMINATED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)NCT04777396 · 2021-05-18 · 1 site observation
COMPLETED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)NCT04777409 · 2021-05-18 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)NCT04548999 · 2020-12-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)NCT04576455 · 2020-11-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)NCT04546009 · 2020-10-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung CancerNCT04205812 · 2020-09-11 · 1 site observation
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)NCT04338022 · 2020-06-12 · 1 site observation
TERMINATED
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced MalignanciesNCT04181788 · 2020-03-18 · 1 site observation
COMPLETED
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)NCT04248829 · 2020-02-13 · 1 site observation
COMPLETED
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerNCT04177108 · 2019-11-25 · 1 site observation
COMPLETED
House Dust Mite Allergy Trial In ChildrenNCT04145219 · 2019-10-12 · 1 site observation
COMPLETED
Durvalumab Long-Term Safety and Efficacy StudyNCT04078152 · 2019-09-05 · 1 site observation
COMPLETED
Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03NCT04109391 · 2019-08-20 · 1 site observation
COMPLETED
A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung AdenocarcinomaNCT03891173 · 2019-02-19 · 1 site observation
TERMINATED
A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic SubjectsNCT03622112 · 2019-01-02 · 1 site observation
COMPLETED
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT03735121 · 2018-12-27 · 1 site observation
COMPLETED
MGD019 DART® Protein in Unresectable/Metastatic CancerNCT03761017 · 2018-12-12 · 1 site observation
COMPLETED
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerNCT03456076 · 2018-08-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerNCT03498716 · 2018-08-02 · 1 site observation
TERMINATED
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast CancerNCT03556358 · 2018-06-28 · 1 site observation
COMPLETED
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerNCT03493854 · 2018-06-14 · 1 site observation
COMPLETED
Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung CancerNCT03088813 · 2018-04-25 · 1 site observation
COMPLETED
Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.NCT03703869 · 2018-03-06 · 1 site observation
COMPLETED
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)NCT03260894 · 2017-12-07 · 1 site observation
COMPLETED
Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)NCT03361865 · 2017-12-04 · 1 site observation
COMPLETED
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersNCT03212404 · 2017-09-20 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of MGD013 in Patients With Unresectable or Metastatic NeoplasmsNCT03219268 · 2017-08-18 · 1 site observation
COMPLETED
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).NCT03164616 · 2017-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)NCT03043872 · 2017-03-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaNCT03052725 · 2017-03-10 · 1 site observation
TERMINATED
MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLCNCT04633564 · 2017-01-21 · 1 site observation
COMPLETED
A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung CancerNCT02937818 · 2016-11-28 · 1 site observation
COMPLETED
Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast CancerNCT03084237 · 2016-11-01 · 1 site observation
COMPLETED
Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid ArthritisNCT02919475 · 2016-09-14 · 1 site observation
COMPLETED
Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung CancerNCT02810457 · 2016-09-07 · 1 site observation
COMPLETED
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung CancerNCT02754882 · 2016-07-05 · 1 site observation
COMPLETED
AMPLIFY - D6571C00001 Duaklir USA Phase III StudyNCT02796677 · 2016-07-05 · 1 site observation
COMPLETED
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung CancerNCT02735980 · 2016-05-11 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)NCT02657434 · 2016-04-30 · 1 site observation
COMPLETED
TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)NCT02676089 · 2016-04-06 · 1 site observation
COMPLETED
A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BCNCT02771795 · 2016-04-01 · 1 site observation
TERMINATED
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsNCT02573259 · 2016-02-10 · 1 site observation
COMPLETED
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)NCT02542293 · 2015-11-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]NCT02486718 · 2015-10-31 · 1 site observation
COMPLETED
Avelumab in First-line NSCLC (JAVELIN Lung 100)NCT02576574 · 2015-10-29 · 1 site observation
COMPLETED
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.NCT02511106 · 2015-10-21 · 1 site observation
ACTIVE_NOT_RECRUITING
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsNCT02501629 · 2015-09-29 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.